Suppr超能文献

miRNA:动脉粥样硬化性卒中基因诊断和治疗的潜在靶点。

MiRNA: a potential target for gene diagnosis and treatment of atherosclerotic stroke.

机构信息

Department of Neurology, Hubei University of Medicine, Shiyan City, Hubei Province, China.

Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, China.

出版信息

Int J Neurosci. 2021 Mar;131(3):283-288. doi: 10.1080/00207454.2020.1738428. Epub 2020 Mar 31.

Abstract

Stroke is one of the major diseases that endanger the physical health life of middle-aged and old people. It has the characteristics of high incidence, mortality and disability rate. Atherosclerosis is the main intervention target for stroke prevention and treatment. MiRNAs are highly expressed in the cerebral vasculature and play an important regulatory role in the pathogenesis of neuronal damage and ischemic stroke. This article reviews the mechanism of action between miRNAs and atherosclerosis, stroke, ischemia-reperfusion injury, collateral circulation and circRNA molecular networks, providing theoretical support for miRNA in gene diagnosis and drug therapy of atherosclerotic stroke.

摘要

中风是危害中老年人身体健康生命的主要疾病之一,具有发病率、死亡率和致残率高的特点。动脉粥样硬化是中风预防和治疗的主要干预靶点。miRNAs 在脑血管中高度表达,在神经元损伤和缺血性中风的发病机制中发挥重要的调节作用。本文综述了 miRNAs 与动脉粥样硬化、中风、缺血再灌注损伤、侧支循环和 circRNA 分子网络之间的作用机制,为 miRNA 在动脉粥样硬化性中风的基因诊断和药物治疗方面提供了理论支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验